SJS Canada - Stevens Johnson Syndrome Canada
learnright-logo
Welcome to SJS Canada.

Our founder and president Sonia W. Croasdaile, unfortunately was stricken with
Stevens Johnson Syndrome and Toxic Epidermal Necrolysis in 2011. Her miraculous survival inspired her
to create a well needed outlet to spead awareness about this life threatening medical illness.

DOWNLOAD OUR BROCHURE

ANNOUNCEMENT

Please join us for an information-sharing night on Stevens-Johnson Syndrome in Canada on
Thursday, November 2, 2017.
Read Full Announcement (UPDATED)

 

What is SJS?
Who We Are!
Give a Gift and Donate

Stevens-Johnson Syndrome (SJS) and Toxic Epidermal Necrolysis (TEN) represent different degrees of a severe, acute, life-threatening mucocutaneous reaction resulting mainly from drugs. Both are considered a medical emergency that requires hospitalization and management of patients is usually provided in intensive care units or burn centers. Recovery can take weeks to months, and there are numerous long-term sequelae. Medications are the major precipitating cause and no specific treatment modality has been proven effective.

By current convention, the following terminology is used: the term SJS is used when the disease involves less than 10% of the total body surface area; and the term TEN is used when the disease involves more than 30% of the body surface area.

SJS Canada Mission:
Our mission is to be the leader in Canada providing support, advocacy and education for the Stevens Johnson Syndrome and Toxic Epidermal Necrolysis patient community.
 
SJS Canada Vision:
To facilitate an umbrella of services for the SJS/TEN patient community in Canada

SJS Canada aims to:
Promote health by providing people suffering from Stevens Johnson Syndrome and Toxic Epidermal Necrolysis (SJS/TEN) as well as their families and caregivers with access to related counselling, support groups and information programs.

Advance education by providing workshops, forums and seminars and tofacilitate a pool of volunteers.

We need your help:
SJS affects 1- 6 per million people every year and TEN affects approximately 0.4 - 1.2 per million people every year. High-quality supportive treatment, ideally in intensive care units is the current standard of care and can improve outcome. No specific therapy has yet shown efficacy.

Your donations will help support the SJS/TEN patient community, raise public awareness, and support the funding of research projects. You will receive a tax receipt for any donation of $20 or more.

DONATE NOW

Download Pledge Form

 

Contact Us

Sonia Whyte-Croasdaile Founder & President
Phone: 416-254-6543 | Email: sjsandtenscanada@gmail.com
Facebook: Sjs Tens CA

BN: 81927 7393 RR0001